Dopamine D4receptor stimulation contributes to novel object recognition: Relevance to cognitive impairment in schizophrenia
- 1 February 2017
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 31 (4) , 442-452
Abstract
Several atypical antipsychotic drugs (APDs) have high affinity for the dopamine (DA) D4receptor, but the relevance to the efficacy for the treatment of cognitive impairment associated with schizophrenia (CIAS) is poorly understood. The aim of this study was to investigate the effects of D4receptor stimulation or blockade on novel object recognition (NOR) in normal rats and on the sub-chronic phencyclidine (PCP)-induced novel object recognition deficit. The effect of the D4agonist, PD168077, and the D4antagonist, L-745,870, were studied alone, and in combination with clozapine and lurasidone. In normal rats, L-745,870 impaired novel object recognition, whereas PD168077 had no effect. PD168077 acutely reversed the sub-chronic phencyclidine-induced novel object recognition deficit. Co-administration of a sub-effective dose (SED) of PD168077 with a sub-effective dose of lurasidone also reversed this deficit, but a sub-effective dose of PD168077 with a sub-effective dose of clozapine, a more potent D4antagonist than lurasidone, did not reverse the sub-chronic phencyclidine-induced novel object recognition deficit. At a dose that did not induce a novel object recognition deficit, L-745,870 blocked the ability of clozapine, but not lurasidone, to reverse the novel object recognition deficit. D4receptor agonism has a beneficial effect on novel object recognition in sub-chronic PCP-treated rats and augments the cognitive enhancing efficacy of an atypical antipsychotic drug that lacks affinity for the D4receptor, lurasidone.Keywords
This publication has 71 references indexed in Scilit:
- Novel Dopamine Therapeutics for Cognitive Deficits in SchizophreniaBiological Psychiatry, 2017
- Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptorsProceedings of the National Academy of Sciences, 2012
- Dopamine D4 Receptor Activation Increases Hippocampal Gamma Oscillations by Enhancing Synchronization of Fast-Spiking InterneuronsPLOS ONE, 2012
- D1 receptor activation improves vigilance in rats as measured by the 5-choice continuous performance testPsychopharmacology, 2011
- Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophreniaPsychopharmacology, 2010
- Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe6-Ang IV in ratsEuropean Neuropsychopharmacology, 2009
- A-412997, a selective dopamine D4 agonist, improves cognitive performance in ratsPharmacology Biochemistry and Behavior, 2005
- Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonismBrain Research, 2004
- Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trialBiological Psychiatry, 2004
- Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J miceBehavioural Brain Research, 2003